First Time Loading...

Neurocrine Biosciences Inc
NASDAQ:NBIX

Watchlist Manager
Neurocrine Biosciences Inc Logo
Neurocrine Biosciences Inc
NASDAQ:NBIX
Watchlist
Price: 143.03 USD 3.99% Market Closed
Updated: May 2, 2024

Neurocrine Biosciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neurocrine Biosciences Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Neurocrine Biosciences Inc
NASDAQ:NBIX
Revenue
$1.9B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
92%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Neurocrine Biosciences Inc
Revenue Breakdown

Breakdown by Geography
Neurocrine Biosciences Inc

Not Available

Breakdown by Segments
Neurocrine Biosciences Inc

Total Revenue: 1.9B USD
100%
Net Product Sales: 1.9B USD
98.6%
Collaboration Revenue: 26.5m USD
1.4%

See Also

What is Neurocrine Biosciences Inc's Revenue?
Revenue
1.9B USD

Based on the financial report for Dec 31, 2023, Neurocrine Biosciences Inc's Revenue amounts to 1.9B USD.

What is Neurocrine Biosciences Inc's Revenue growth rate?
Revenue CAGR 10Y
92%

Over the last year, the Revenue growth was 27%. The average annual Revenue growth rates for Neurocrine Biosciences Inc have been 22% over the past three years , 33% over the past five years , and 92% over the past ten years .